PTC Taps Genzyme’s Global Reach, Pocketbook In Ultra-orphan Licensing Deal

PTC124 offers new approach for treating lysosomal storage disorders central to Genzyme’s success, as well as other genetic diseases.

More from Archive

More from Pink Sheet